Last reviewed · How we verify

NCT05009381

Effectiveness and Safety of STYLAGE® XXL for Chin Augmentation in Chinese Adults

Completed NA Last updated 21 September 2023
What this trial tests

NA trial testing Stylage XXL at enrollment in Esthetic in 174 participants. Completed in 31 August 2023.

Timeline
10 September 2021
Primary endpoint
26 October 2022
31 August 2023

Quick facts

Lead sponsorLaboratoires Vivacy
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment174
Start date10 September 2021
Primary completion26 October 2022
Estimated completion31 August 2023
Sites5 locations across China

Drugs / interventions tested

Conditions studied

Sponsor

Laboratoires Vivacy

Who can join

18 and older, any sex, with Esthetic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this trial is to demonstrate the efficacy and safety of STYLAGE® XXL in augmenting the chin volume among Chinese adults. Subjects will be randomized either to the treatment group or the control group in a 4:1 ratio The superiority of STYLAGE® XXL against no-treatment control in chin volume augmentation will be verified together with assessments of the safety profiles.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Laboratoires Vivacy trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05009381.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing